Literature DB >> 22751136

Strain-specific variation in murine natural killer gene complex contributes to differences in immunosurveillance for urethane-induced lung cancer.

Daniel Kreisel1, Andrew E Gelman, Ryuji Higashikubo, Xue Lin, Haris G Vikis, J Michael White, Kelsey A Toth, Charuhas Deshpande, Beatriz M Carreno, Ming You, Samantha M Taffner, Wayne M Yokoyama, Jack D Bui, Robert D Schreiber, Alexander S Krupnick.   

Abstract

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide and results from a complex interaction between carcinogen exposure and inherent susceptibility. Despite its prevalence, genetic factors that predispose to the development of lung cancer remain elusive. Inbred mouse models offer a unique and clinically relevant tool to study genetic factors that contribute to lung carcinogenesis due to the development of tumors that resemble human adenocarcinoma and broad strain-specific variation in cancer incidence after carcinogen administration. Here, we set out to investigate whether strain-specific variability in tumor immunosurveillance contributes to differences in lung cancer. Using bone marrow transplantation, we determined that hematopoietic cells from lung cancer-resistant mice could significantly impede the development of cancer in a susceptible strain. Furthermore, we show that this is not due to differences in tumor-promoting inflammatory changes or variability in immunosurveillance by the adaptive immune system but results from strain-specific differences in natural killer (NK) cell cytotoxicity. Using a newly discovered congenic strain of mice, we show a previously unrecognized role for strain-specific polymorphisms in the natural killer gene complex (NKC) in immunosurveillance for carcinogen-induced lung cancer. Because polymorphisms in the NKC are highly prevalent in man, our data may explain why certain individuals without obvious risk factors develop lung cancer whereas others remain resistant to the disease despite heavy environmental carcinogen exposure. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22751136      PMCID: PMC3432713          DOI: 10.1158/0008-5472.CAN-12-0908

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

Review 1.  Immune functions encoded by the natural killer gene complex.

Authors:  Wayne M Yokoyama; Beatrice F M Plougastel
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

Review 2.  Role of inflammation in mouse lung tumorigenesis: a review.

Authors:  Alvin M Malkinson
Journal:  Exp Lung Res       Date:  2005 Jan-Feb       Impact factor: 2.459

3.  IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.

Authors:  V Shankaran; H Ikeda; A T Bruce; J M White; P E Swanson; L J Old; R D Schreiber
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

4.  Genealogies of mouse inbred strains.

Authors:  J A Beck; S Lloyd; M Hafezparast; M Lennon-Pierce; J T Eppig; M F Festing; E M Fisher
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

5.  Five loci, SLT1 to SLT5, controlling the susceptibility to spontaneously occurring lung cancer in mice.

Authors:  Daolong Wang; Ming You
Journal:  Cancer Res       Date:  2005-09-15       Impact factor: 12.701

6.  Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice.

Authors:  Pengyuan Liu; Yian Wang; Haris Vikis; Anna Maciag; Daolong Wang; Yan Lu; Yan Liu; Ming You
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

7.  Strain differences in natural killer cell-mediated immunity among mice: a possible mechanism for the low natural killer cell activity of A/J mice.

Authors:  A L Whyte; S C Miller
Journal:  Immunobiology       Date:  1998-07       Impact factor: 3.144

8.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement.

Authors:  Y Shinkai; G Rathbun; K P Lam; E M Oltz; V Stewart; M Mendelsohn; J Charron; M Datta; F Young; A M Stall
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

9.  Susceptibility of various strains of mice to urethan-induced lung tumors and depressed natural killer cell activity.

Authors:  E Gorelik; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1981-12       Impact factor: 13.506

10.  Positional cloning of the major quantitative trait locus underlying lung tumor susceptibility in mice.

Authors:  Zhongqiu Zhang; Manabu Futamura; Haris G Vikis; Min Wang; Jie Li; Yian Wang; Kun-Liang Guan; Ming You
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-28       Impact factor: 11.205

View more
  11 in total

Review 1.  Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research.

Authors:  Yewei Liu; Ting Yin; Yuanbo Feng; Marlein Miranda Cona; Gang Huang; Jianjun Liu; Shaoli Song; Yansheng Jiang; Qian Xia; Johannes V Swinnen; Guy Bormans; Uwe Himmelreich; Raymond Oyen; Yicheng Ni
Journal:  Quant Imaging Med Surg       Date:  2015-10

2.  Genetic diversity and tumor immunesurveillance.

Authors:  Mari Hirvinen; Vincenzo Cerullo
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

3.  Genetic variation of the natural killer gene complex has a role in lung cancer susceptibility.

Authors:  Ryan W Logan; Dipak K Sarkar
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

Review 4.  The paradoxical role of tumor-infiltrating immune cells in lung cancer.

Authors:  Xiaodan Zheng; Yuhai Hu; Chengfang Yao
Journal:  Intractable Rare Dis Res       Date:  2017-11

5.  A reengineered common chain cytokine augments CD8+ T cell-dependent immunotherapy.

Authors:  Anirban Banerjee; Dongge Li; Yizhan Guo; Zhongcheng Mei; Christine Lau; Kelly Chen; John Westwick; Jeffery B Klauda; Adam Schrum; Eric R Lazear; Alexander S Krupnick
Journal:  JCI Insight       Date:  2022-05-23

6.  Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer.

Authors:  Lei Shi; Kang Li; Yizhan Guo; Anirban Banerjee; Qing Wang; Ulrike M Lorenz; Mahmut Parlak; Lucy C Sullivan; Oscar Okwudiri Onyema; Saeed Arefanian; Edward B Stelow; David L Brautigan; Timothy N J Bullock; Michael G Brown; Alexander Sasha Krupnick
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-31       Impact factor: 11.205

7.  Unique pulmonary antigen presentation may call for an alternative approach toward lung cancer immunotherapy.

Authors:  Stephanie Chang; Xue Lin; Ryuji Higashikubo; Kelsey Toth; Andrew E Gelman; Daniel Kreisel; Alexander S Krupnick
Journal:  Oncoimmunology       Date:  2013-03-01       Impact factor: 8.110

8.  Immune cell-based screening assay for response to anticancer agents: applications in pharmacogenomics.

Authors:  Amber Frick; Yuri Fedoriw; Kristy Richards; Blossom Damania; Bethany Parks; Oscar Suzuki; Cristina S Benton; Emmanuel Chan; Russell S Thomas; Tim Wiltshire
Journal:  Pharmgenomics Pers Med       Date:  2015-02-26

9.  Natural killer cells in non-hematopoietic malignancies.

Authors:  Mélanie Desbois; Sylvie Rusakiewicz; Clara Locher; Laurence Zitvogel; Nathalie Chaput
Journal:  Front Immunol       Date:  2012-12-24       Impact factor: 7.561

10.  Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy.

Authors:  Reza Ghasemi; Eric Lazear; Xiaoli Wang; Saeed Arefanian; Alexander Zheleznyak; Beatriz M Carreno; Ryuji Higashikubo; Andrew E Gelman; Daniel Kreisel; Daved H Fremont; Alexander Sasha Krupnick
Journal:  Nat Commun       Date:  2016-09-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.